CARDARINE GW501516

PPARδ Agonist for Metabolic & Endurance Research

VST Research Labs Cardarine (GW501516) is a laboratory‑grade research compound designed to investigate metabolic and endurance signalling pathways through the activation of peroxisome proliferator‑activated receptor delta (PPARδ). Often categorised alongside investigational compounds targeting metabolism and energy utilisation, GW501516 is used in controlled research settings where precise, high‑purity compounds are required.

Main Research Benefits of Cardarine (GW501516)

• Supports research into enhanced fatty acid oxidation and metabolic efficiency 
• May help investigate endurance and stamina pathways in laboratory models 
• Useful for metabolic signalling studies involving energy substrate utilisation 
• Often combined with other compounds in stacks to explore combined effects on body composition and conditioning

How Cardarine Works (Research Mechanism)

Cardarine (GW501516) is a synthetic agonist of the **PPARδ receptor**, a receptor involved in the regulation of lipid metabolism and cellular energy pathways. By activating PPARδ, GW501516 influences the expression of genes associated with fatty acid oxidation and mitochondrial function, potentially shifting energy utilisation toward fat as a substrate in lab studies. 

Research has shown that GW501516 can increase the expression of enzymes and transporters connected to oxidative metabolism in muscle tissue and influence endurance‑related gene expression profiles in experimental models. 

Product Features & Specifications

• Brand: VST Research Labs
• Compound: Cardarine (GW501516)
• Form: Capsules (typically 10 mg per capsule — check product label)
• Action: PPARδ agonist targeting metabolic and endurance pathways
• Use: Strictly for laboratory and scientific research — not approved for human or veterinary use

Suggested Research Usage

In research environments, Cardarine is typically administered once daily with meals or according to experimental protocol to support consistent exposure throughout the study period. Dosing is adjusted based on study design and compound stability requirements.

⚠️ Important: VST Research Labs Cardarine (GW501516) is intended exclusively for **research use**. It is not approved as a dietary supplement, therapeutic drug, or for human or veterinary consumption. Always follow local laws, safety protocols, and ethical guidelines.

Frequently Asked Questions

What is Cardarine (GW501516)?

Cardarine — also called GW501516 — is a **PPARδ agonist** that influences metabolic signalling and energy substrate pathways. It has been widely studied in research contexts for its effects on fatty acid oxidation and endurance models. 

How does Cardarine differ from SARMs?

Although often grouped with SARMs in commercial listings, Cardarine is **not a SARM**. Instead, it acts on the PPARδ receptor, affecting metabolic and energy utilisation pathways without directly binding to androgen receptors. 

Is Cardarine approved for human use?

No — GW501516 has *never been approved* for human or veterinary use, and clinical development was halted due to safety concerns observed in animal studies. It is also banned by anti‑doping agencies in professional sport.

What are the potential research risks?

Some preclinical research indicates potential long‑term safety concerns, such as liver and cancer risks at high exposures in animal models, underscoring the need for careful laboratory protocols.

Investigate metabolic & endurance pathways with VST Research Labs Cardarine (GW501516) — a high‑purity research compound formulated for controlled studies into fatty acid oxidation and metabolic signalling.